Bausch Health Companies Inc (BHC TO) stock market data APIs
C$9.287
0.61(6.6%)
as of September 16, 2025
Try our APIs with
free plan!
Bausch Health Companies Inc Financial Data Overview
Price chart is built with
Anychart
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Prev. Close
9.287
Open
9.8948
High
9.8948
Low
9.3125
52 wk Range
5.91-13.74
Market Cap
3 443 M
P/E Ratio
25.8611
Shares Outstanding
370 M
Revenue
9 858 M
EPS
0.91
Beta
0.477
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bausch Health Companies Inc (top by weight)
Ticker
100-day Price Change
Weight
IS0S.F
iShares III Public Limited Company - iShares Emerging Asia Local Government Bond UCITS ETF
-3.44
(-4.37%)
0.03
IS0P.F
iShares V Public Limited Company - iShares Spain Government Bond UCITS ETF
-1.38
(-0.9%)
0.03
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bausch Health Companies Inc data using free add-ons & libraries
Get Bausch Health Companies Inc Fundamental Data
Bausch Health Companies Inc Fundamental data includes:
- Net Revenue: 9 858 M
- EBITDA: 3 110 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-30
- EPS/Forecast: 0.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bausch Health Companies Inc News
New
Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bausch Health Companies is one of them. Bausch Health Companies Inc. (NYSE:BHC), a global specialty pharmaceuti...
Bausch Health Completes US$63 Million Durect Acquisition, Adds Breakthrough Hepatitis Therapy to Pipeline
Bausch Health Companies (BHC.TO) Thursday said it completed its acquisition of Durect for US$1.75 pe PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline LA...
Bausch Health (NYSE:BHC): Revisiting Valuation After Recent Share Price Momentum
Bausch Health Companies (NYSE:BHC) is turning heads among investors yet again, with recent moves in its stock price prompting a familiar question: is there more than meets the eye here? While there ha...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
